Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India

PURPOSE: We undertook this study to evaluate the incremental cost per quality-adjusted life-year (QALY) gained with use of adjuvant trastuzumab as compared with chemotherapy alone among patients with nonmetastatic breast cancer in India. METHODS: We used a Markov model to estimate the incremental co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Nidhi, Verma, Rohan Kumar, Gupta, Sudeep, Prinja, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051799/
https://www.ncbi.nlm.nih.gov/pubmed/32045547
http://dx.doi.org/10.1200/JGO.19.00293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051799/
https://www.ncbi.nlm.nih.gov/pubmed/32045547
http://dx.doi.org/10.1200/JGO.19.00293

Ejemplares similares